Rapport Therapeutics Ratios (2023-2026) | RAPP

Ratios Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -718.46%
EBIT Margin (Quarter) -121.08%
EBITDA Margin (Quarter) -121.08%
Operating Margin (Quarter) -121.08%
Net Margin (Quarter) -99.29%
FCF Margin (Quarter) -65.74%
Efficiency
Assets Average (Quarter) 338.62M323.04M308.49M293.77M410.41M523.88M505.01M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -0.69-1.13-0.37-0.48-0.690.00-1.76-0.27-0.34-0.20
Times Interest Earned (Quarter) -0.69-1.13-0.37-0.48-0.690.00-1.76-0.27-0.34-0.20
Valuation
Enterprise Value (Quarter) -79.53M-159.41M-70.25M-74.37M-110.27M-39.42M-305.28M-57.71M-465.78M-513.11M-52.75M-476.78M
Return Ratios
Return on Sales (Quarter) -0.07%
Return on Capital Employed (Quarter) -22.42%-26.43%-31.12%-36.10%-27.80%-24.78%-25.09%
Return on Assets (Quarter) 0.00%0.00%-0.40%-0.42%-0.30%-0.24%-0.01%